28
Oct
2025

Fujian Genohope Biotech Ltd

Exhibitor at CPHI Frankfurt 2025 stand 3.0A88, Finished Dosage Formulations
About Us

Fujian Genohope Biotech Ltd. manufacture Semaglutide via both synthetic and fermention routes respectively, and we also have Tirzepatide. We belong to New Hope Group, one of the world's top 500 enterprises.We are FDA-approved GMP facility and producing Semaglutide DMFs (recombinant and synthetic) with NDCs.

  • CN
  • 2020
    On CPHI since
  • 1
    Certificates
  • 250 - 499
    Employees
Company types
Biopharmaceutical company
Consumer Goods
Primary activities
API Producer
Biopharmaceutical
Generic APIs producer
Intermediates Manufacturer
Contact info
  • No.288 Xitang Street, Hushi l. Park,, Xiuyu District, 351146, Putian City, Fujian, China
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe Frankfurt
  • Visit us at stand 3.0A88, Finished Dosage Formulations

Products Featured at CPHI Frankfurt 2025